Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Scabies

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44364   clinical trials with a EudraCT protocol, of which   7388   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    8 result(s) found for: Scabies. Displaying page 1 of 1.
    EudraCT Number: 2022-000660-22 Sponsor Protocol Number: Benzylbenzoat-Permethrin-5020 Start Date*: 2022-06-14
    Sponsor Name:Landeskrankenhaus Salzburg
    Full Title: Investigation to assess the efficacy of topical benzyl benzoate 10/25% emulsion versus permethrin 5% creme for scabies treatment
    Medical condition: Scabies
    Disease:
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-006778-26 Sponsor Protocol Number: 07ct/am04perm Start Date*: 2008-07-17
    Sponsor Name:gepepharm GmbH
    Full Title: Investigation of the local tolerability of pedimitex creme 5% - a permethrine containing creme - in 100 patients with scabies infection of both gender
    Medical condition: The product is intended to be used by patients suffering from scabies infestation
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039512 Scabies infestation LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: BG (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-004494-27 Sponsor Protocol Number: 5020DERM-2018 Start Date*: Information not available in EudraCT
    Sponsor Name:Landeskrankenhaus Salzburg
    Full Title: pilotstudy- efficacy of infectoscab 5% creme in patients with scabies
    Medical condition: Scabies
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10039511 Scabies LLT
    20.0 10021881 - Infections and infestations 10063409 Acarodermatitis PT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-003255-15 Sponsor Protocol Number: Benzylbenzoat-Ivermectin-5020 Start Date*: 2020-12-17
    Sponsor Name:Landeskrankenhaus Salzburg
    Full Title: Investigation to assess the efficacy of benzyl benzoate 10/25% emulsion versus oral ivermectin for scabies treatment
    Medical condition: Scabies
    Disease:
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-001775-37 Sponsor Protocol Number: MDGH-MOX-2001 Start Date*: 2019-09-20
    Sponsor Name:Medicines Development Limited (trading as Medicines Development for Global Health)
    Full Title: A Phase II, randomized, double-blind, parallel group dose finding study of single oral doses of moxidectin in adults with scabies
    Medical condition: Scabies (infection with Sarcoptes scabiei)
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004862 10039511 Scabies LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) AT (Completed)
    Trial results: View results
    EudraCT Number: 2019-003234-16 Sponsor Protocol Number: ETSKABI Start Date*: 2021-01-26
    Sponsor Name:InfectoPharm Arzneimittel und Consilium GmbH
    Full Title: Prospektive, offene, multizentrische, initial 1-armige und bei Therapieversagen 3-armig randomisierte klinische Prüfung der Phase III/IV zur eskalierenden Therapie der Skabies mit INFECTOSCAB 5% (P...
    Medical condition: Scabies
    Disease:
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2019-000735-61 Sponsor Protocol Number: SP-NAC19 Start Date*: 2021-04-06
    Sponsor Name:Dutch Growth Research Foundation
    Full Title: N- acetylcysteine treatment for skin picking in children and young adults with PWS: a randomized, controlled, cross-over trial.
    Medical condition: Prader-Willi syndrome
    Disease: Version SOC Term Classification Code Term Level
    20.0 10010331 - Congenital, familial and genetic disorders 10036476 Prader-Willi syndrome PT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2018-001219-53 Sponsor Protocol Number: TR11 Start Date*: 2019-03-06
    Sponsor Name:Trevi Therapeutics, Inc.
    Full Title: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy and Safety Study in Prurigo Nodularis with Nalbuphine ER Tablets for Pruritus Relief Through Itch Scratch Modulation (PRI...
    Medical condition: Prurigo Nodularis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004858 10037084 Prurigo nodularis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) FR (Completed) AT (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun Nov 16 12:24:36 CET 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA